Pediatric AIDS Clinical Trials Group 076 (PACTG 076)
Audio
A federally funded study that determined that the risk of mother-to-child transmission (MTCT) of HIV could be reduced by nearly 70% if the antiretroviral (ARV) drug zidovudine was given to a woman during pregnancy and labor and delivery and to the newborn. The Pediatric AIDS Clinical Trials Group 076 (PACTG 076) study contributed greatly to preventing MTCT of HIV.
Download Glossary
-
English Version PDF(3.13MB)
-
Spanish Version PDF(3.16MB)